Dr. Rajah Vijay Kumar D.Sc.
Rajah Vijay Kumar is the Group Chairman of Organization de Scalene, Director and Chief Scientific officer of the Centre for Advanced Research and Development (CARD), Director of Scalene Energy Research Institute (SERI) and Managing Director of Scalene Cybernetics limited and currently serves as Chairman of the board of Directors for over eight global organizations.
He has over 30 years of research, development and global business experience and 25 years of meaningful existence of Organization De Scalene founded by him. He founded Organization De Scalene in 1993, to promote Science and Technology in the areas of Healthcare, Energy, Food, Water and Quality of Life, with a global interest. Rajah Vijay Kumar., now 53, is a Bachelor of Science graduate, majoring in Physics, Chemistry and Mathematics, a post graduate in Microelectronics and a Doctor of Science in Medical Engineering (magna cum laude), and also holds a Master of Business Administration in Corporate Crisis Management. He is a pioneering researcher and an opinion leader in the field of Biophysics, Radiobiology, Nanotechnology and Sustainable Energy. Specialized in Electronics and Bio-medical Engineering, he has worked for more than twenty years on regenerative tissue engineering and high speed biological data acquisition, modelling and simulation of the human cardiovascular system, artificial intelligence and neural networks in medical diagnosis and engineering. Among the many patents held by him, they include the Realistic Geometry Cartographic Imaging (RGCI) which finds applications from medical science to tsunami detection, and the CYTOTRON® which is considered an important milestone in radiobiology and tissue engineering.
He holds the US, European and Chinese patents for the CYTOTRON® for Degenerative and Regenerative Tissue Engineering. His work on Nanotechnology sparked a new technique in selective tissue destruction with a "nanoblaster" that is undergoing laboratory trials. He also holds the US patent for Focused Nano-Permeabilization (FORN) technology etc. for targeted, precise cancer drug delivery. His medical devices have been approved by the regulatory bodies like the European Body (CE), the Saudi-FDA, and the Asian bodies, with the HAEMOSEIS-256 now being approved for commercialization by the COFEPRIS in Mexico. He has invented SPARSE™ technology for fuel enrichment and its application in renewable energy production. Fluid Ignition Engine (FIT), the TMD reactor for high intensity megasonic break-down of long chain hydrocarbons and Transcutaneous Thermoelectroporic Omni-molecular drug delivery systems, are his other inventions, to name a few. He is a chronic Inventor with more than fifteen patents to his credit. He has many publications both in medical and engineering journals of repute. He is also the Author of the book Cytonics - a mystery of the living cell.
He first founded Scalene Engineers Private Limited (SEPL) to design, develop and provide engineering solutions to human problems. First identified area of interest was healthcare which led to the invention, design and manufacture of diagnostic and therapeutic Medical Devices under the techno-commercial co-operation of ASKIT Limited of Hungary. The first of the products were Ambulatory Blood Pressure Monitoring System (ABPM) and Non-Invasive Cardiac output Monitors. The first of the ABPM’s supplied 18 years ago is still working and is in use with the commercial Airliner-Air India, its first customer.
Dr. Kumar started independent research into cardiovascular cartography in 1993 and successfully developed the first prototype of HAEMOTRON in 1998. Early cardiovascular studies on Indian air force pilots were carried out with Dr. Rayol John Augustus, at the Flight Simulation Division, Aeronautical Development Establishment, Defence Research and Development Organization (DRDO), Ministry of Defence, Bangalore India. These studies were also the basis for Ph.D. projects in cardiology. The first basic device was proposed as a non-invasive standard test for Indian Air Force pilots. The first prototype of the HAEMATRON was developed in 1998. The result of the early studies was first presented at the European Society of Cardiology congress in Barcelona, Spain in 1999, and later at the IEEE-CBMS, at the National Institutes of Health, Bethesda, USA in 2001. The HEMOSEIS 256™ is a CE certified diagnostic device that provides comprehensive information on cardio-pulmonary and renal physiology within 256 heart-beats. The device has received FDA’s “non-significant risk” certification based on a pilot study conducted in the USA by Shreis Scalene Cardiotech LLC. HAEMOTRON was commercialized in 1999 and today there are over 150 installations in about 20 countries. HAEMOTRON was renamed as HAEMOSEIS-256 in 2003.
Simultaneously with the developments in Medical engineering, Dr. Kumar and his organization were active in defence research with the collaboration with the Ministry of Defence, Electronics Directorate, and Republic of Hungary. Scalene worked on Force on Force Combat Training Systems (FOFTF), with MCEME in India. Global Positioning Systems (GPS) was another area that Scalene was actively participating. First ever cross country dynamic object tracking was conducted by Scalene, by dynamically tracking a moving object from Bangalore to Kashmir in 1999.
In the year 2000, Scalene Cybernetics Limited was established, with its research and development wing, the Centre for Advanced Research and Development (CARD). Scalene Engineers transferred all ongoing research projects to CARD.
In 2001, Dr. Kumar established the Scalene- Center for Advanced Research and Design (S-CARD) campus in Bangalore. The other patented therapeutic medical device is the CYTOTRON® that uses safe, non-ionizing radio-frequency coupled with instantaneous magnetic resonance to treat degenerative musculoskeletal and neurological diseases like OA and MS and proliferative diseases like Cancer. CYTOTRON research started by Dr. Kumar in 1987, was re-initiated by Scalene Engineers in 1996 , and was also transferred to CARD. In 1999 CARD produced the first prototype of CYTOTRON a 96-gun version for radiobiology application. There after three more prototypes were developed. Clinical trials were conducted on volunteer patients, in collaboration with the Institute of Aerospace Medicine, Indian Air Force. The results were remarkable. Cytotron was selectively commercialized in July 2006, and ever since there has been 29 “selected” installations in India and abroad. Benefits of CYTOTRON as a tissue engineering tool will find applications in Medicine, Microbial-Biofuel and energy crops, Agriculture, Seri-culture and other life sciences. He is an expert in biogas waste to energy management and has pioneered work in India on Nano porous molecular capture for more efficient storage of biogas. He has authored many publications both in medical and engineering journals of repute and is a member of the United Inventors Association (UIAUS) and the Institute of Electrical and Electronics Engineers (IEEE).
In 2002, Dr. Kumar established a new research wing in the next promised area, Energy, thus the Scalene Energy Research Institute (SERI) was born. SERI has brought out six technologies in the area of Sustainable Energy, Oil and Gas, down- stream processing, storage, Electricity Generation, and recently initiated the “Surya Putra Project”, the Extremely Efficient Solar Hydrogen (EESH) technology etc. To commercialize some of these technologies, it established the Scalene Greenergy Corporation Limited in 2010, in Bangalore and ever since it executed four mega projects handling 50 tons of feed stock capable of generating 10.95 million units of electricity per annum, with a plant load factor of 96% and at the lowest ever possible cost.
With his interest in robotics and automation, in 2011, Dr. Kumar spear headed the specialized area of Automation, Robotics and Non-linier SCADA or Bio-SCADA, with the establishment of its State-of-the art Automation & Robotics center at the Scalene Bangalore Campus. SEPL now takes up automation solution under the modernization programs of Cement, Power, Chemical, and steel Plants besides handling the internal automation and robotic requirements.
The Youngest member of the Organization De Scalene is Scalene Guha Ventures Private Limited (SGVL), based in Chennai, India. SGVL shall provide some of the best solutions in large ventures in Low grade gas and petroleum processing, Infrastructure, Drinking Water, Scientific Sanitation and sustainable Entrepreneurship. SGVL is already working on a solution to extract and process 64 billion cubic-meter low grade natural gas in the depths of the Lake Kivu, one of the ten great lakes, mandated by the Government of the Republic of Rwanda with an estimated cost of $.100 Million during the first phase. SGVL has also provided a solution to chill 20KL of milk every day in each village, using 8 tons of cow dung as a packaged unit, to some of the east African countries. SGVL is a “Profit with a Purpose” company.
He is the member of the United Inventors Association (UIAUS), the Institute of Electrical and Electronics Engineers (IEEE) and its Engineering in Medicine and Biology Society (EMBS), the Fellow of United Writer’s Association (UWA), and the Member of the American Chemical Society (ACS). He lives in Bangalore; he is married with three daughters. He currently serves on the board of six global organizations. He has been invited as an advisor to the UN educational board. Early this year Dr. Kumar was named as one of India’s top 10 scientists recognized by the Government of India.